# Esophageal Hypersensitivity Study in Healthy Volunteers

> **NCT00711048** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 45 (estimated)

## Conditions studied

- Pain
- Esophageal Sensitivity

## Interventions

- **DRUG:** AZD1386
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00711048
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** —
- **Final completion:** 2009-07
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2009-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711048, "Esophageal Hypersensitivity Study in Healthy Volunteers". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00711048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*